Literature DB >> 32038950

Shaping the future of renal denervation-the relevance of sham-controlled randomized trials and recent meta-analyses.

Márcio G Kiuchi1, Jan K Ho1, Leslie Marisol Lugo Gavidia1, Markus P Schlaich1,2,3.   

Abstract

Year:  2019        PMID： 32038950      PMCID： PMC6987509          DOI： 10.21037/cdt.2019.07.03

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  21 in total

1.  Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study.

Authors:  Eamon Dolan; Alice Stanton; Lut Thijs; Kareem Hinedi; Neil Atkins; Sean McClory; Elly Den Hond; Patricia McCormack; Jan A Staessen; Eoin O'Brien
Journal:  Hypertension       Date:  2005-06-06       Impact factor: 10.190

2.  Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis.

Authors:  Fadl Elmula M Fadl Elmula; Ying-Mei Feng; Lotte Jacobs; Anne C Larstorp; Sverre E Kjeldsen; Alexandre Persu; Jan A Staessen
Journal:  Blood Press       Date:  2017-04-26       Impact factor: 2.835

3.  Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.

Authors:  Michel Azizi; Marc Sapoval; Philippe Gosse; Matthieu Monge; Guillaume Bobrie; Pascal Delsart; Marco Midulla; Claire Mounier-Véhier; Pierre-Yves Courand; Pierre Lantelme; Thierry Denolle; Caroline Dourmap-Collas; Hervé Trillaud; Helena Pereira; Pierre-François Plouin; Gilles Chatellier
Journal:  Lancet       Date:  2015-01-26       Impact factor: 79.321

4.  Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.

Authors:  David E Kandzari; Deepak L Bhatt; Sandeep Brar; Chandan M Devireddy; Murray Esler; Martin Fahy; John M Flack; Barry T Katzen; Janice Lea; David P Lee; Martin B Leon; Adrian Ma; Joseph Massaro; Laura Mauri; Suzanne Oparil; William W O'Neill; Manesh R Patel; Krishna Rocha-Singh; Paul A Sobotka; Laura Svetkey; Raymond R Townsend; George L Bakris
Journal:  Eur Heart J       Date:  2014-11-16       Impact factor: 29.983

5.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

6.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.

Authors:  Clara K Chow; Koon K Teo; Sumathy Rangarajan; Shofiqul Islam; Rajeev Gupta; Alvaro Avezum; Ahmad Bahonar; Jephat Chifamba; Gilles Dagenais; Rafael Diaz; Khawar Kazmi; Fernando Lanas; Li Wei; Patricio Lopez-Jaramillo; Lu Fanghong; Noor Hassim Ismail; Thandi Puoane; Annika Rosengren; Andrzej Szuba; Ahmet Temizhan; Andy Wielgosz; Rita Yusuf; Afzalhussein Yusufali; Martin McKee; Lisheng Liu; Prem Mony; Salim Yusuf
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

7.  Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.

Authors:  Michel Azizi; Roland E Schmieder; Felix Mahfoud; Michael A Weber; Joost Daemen; Justin Davies; Jan Basile; Ajay J Kirtane; Yale Wang; Melvin D Lobo; Manish Saxena; Lida Feyz; Florian Rader; Philipp Lurz; Jeremy Sayer; Marc Sapoval; Terry Levy; Kintur Sanghvi; Josephine Abraham; Andrew S P Sharp; Naomi D L Fisher; Michael J Bloch; Helen Reeve-Stoffer; Leslie Coleman; Christopher Mullin; Laura Mauri
Journal:  Lancet       Date:  2018-05-23       Impact factor: 79.321

Review 8.  Renal denervation for resistant hypertension.

Authors:  Giuseppe Coppolino; Anna Pisano; Laura Rivoli; Davide Bolignano
Journal:  Cochrane Database Syst Rev       Date:  2017-02-21

9.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321
View more
  1 in total

Review 1.  Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?

Authors:  Zaman Mirzadeh; Chelsea L Faber; Michael W Schwartz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2022-01-06       Impact factor: 13.820
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.